DELFI uses artificial intelligence and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.
View Top Employees from DELFI Diagnostics| Website | http://www.delfidiagnostics.com |
| Revenue | $5.1 million |
| Employees | 198 (198 on RocketReach) |
| Founded | 2019 |
| Address | 2809 Boston St Suite 503, Baltimore, Maryland 21224, US |
| Phone | (800) 589-2182 |
| Technologies |
JavaScript,
HTML,
PHP
+51 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Decision/Risk Analysis, Business Services, Other Healthcare Services |
| Keywords | Early Cancer Detection, Molecular Diagnostics, Cancer Screening, Cancer Research, Personalized Cancer Care |
| Competitors | Acuamark Diagnostics, Inc., Freenome, GRAIL, GenQual Corp., Wattmo |
| SIC | SIC Code 80 Companies, SIC Code 807 Companies |
| NAICS | NAICS Code 62 Companies, NAICS Code 62151 Companies, NAICS Code 6215 Companies, NAICS Code 621 Companies |
Looking for a particular DELFI Diagnostics employee's phone or email?
DELFI Diagnostics Questions
The DELFI Diagnostics annual revenue was $5.1 million in 2024.
Jenn Buechel is the President and Chief Operating Officer of DELFI Diagnostics.
198 people are employed at DELFI Diagnostics.
DELFI Diagnostics is based in Baltimore, Maryland.
The NAICS codes for DELFI Diagnostics are [62, 62151, 6215, 621].
The SIC codes for DELFI Diagnostics are [80, 807].
Top DELFI Diagnostics Employees
-
24
-
5+3
-
5+5+
-
2
-
44
-
31
-
43
-
23
-
25+
Related Companies
